Kenneth Sultzbaugh
8Patents
5h-index
7Co-inventors
56Inventor score
Filing activity: Mar 21, 1995 → Feb 21, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5686113A | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses | Human Necessities | 69 | Expired |
| US9314429B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 16 | Active |
| US7767225B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 8 | Active |
| US9616018B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 5 | Active |
| US7988994B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 5 | Active |
| US8383150B2 | Granulate formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 4 | Active |
| US8753679B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 2 | Active |
| US10028909B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.